Medications such as Ozempic, Wegovy, and Mounjaro have brought GLP-1 into the spotlight by mimicking this natural hormone to improve metabolic control
We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1 Clearly showing which GLP-1s are currently in shortage by drug and dose 2 Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3 Letting anyone join our Supply List that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4 Sending automated notifications to patients and providers who sign-up letting them know when a drugs status changes on the FDAs list
Donald Norman coined the concept of Emotional Design,15 which proposes that users engage with products at three levels: Visceral: The instinctive level comprising gut reactions driven by evolutionarily derived aesthetic preferences
Black communities are 20% more likely to get colorectal cancer and 40% more likely to die from it
they represent a powerful new tool
Access Issues Shortages and insurance barriers create major obstacles for patients needing GLP-1 medications
